Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: a case-control study

J Int Med Res. 2017 Dec;45(6):2110-2118. doi: 10.1177/0300060517709613. Epub 2017 Jun 23.

Abstract

Objective Acute organ embolism in children with Mycoplasma pneumoniae pneumonia (MPP) has been reported, but changes in coagulation are unclear. This study aimed to investigate changes in coagulation in children with MPP. Methods A total of 185 children with MMP (cases) and 117 healthy children (controls) were recruited. We measured prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and plasma fibrinogen (FIB) and D-dimer levels. Results Plasma FIB (3.39 ± 0.96 g/L vs 2.93 ± 0.6 6g/L, t = 4.50) and D-dimer (326.45 ± 95.62mg/L vs 263.93 ± 103.32mg/L, t=5.36) in MPP children were higher than controls and PT (9.54 ± 4.97S vs 11.48 ± 5.96S, t=3.05) and APTT (31.41 ± 12.01S vs 38.38 ± 11.72S, t=4.95) were shorter than controls. FIB, D-dimer, PT, and APTT were not different between the high IgM-titre and low-titre groups. The areas under the receiver operating characteristic curves in cases and controls for plasma FIB and D-dimer levels were 0.654 (95% confidence interval [CI], 0.593-0.716, P = 0.031) and 0.682 (95% CI, 0.619-0.744, P = 0.032), respectively. Conclusions Children with MPP have a higher risk of blood coagulation and thrombosis. Controlling these problems should be considered as soon as possible.

Keywords: Mycoplasma pneumoniae; children; coagulation function.

MeSH terms

  • Blood Coagulation*
  • Case-Control Studies
  • Child
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Fibrinogen / metabolism
  • Humans
  • Male
  • Mycoplasma pneumoniae / physiology*
  • Partial Thromboplastin Time
  • Pneumonia, Mycoplasma / blood*
  • Pneumonia, Mycoplasma / microbiology*
  • Prothrombin Time
  • ROC Curve

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Fibrinogen